S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.

PHASE3CompletedINTERVENTIONAL
Enrollment

6,097

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

December 31, 2017

Study Completion Date

March 29, 2021

Conditions
Breast Cancer
Interventions
DRUG

clodronate disodium

Given orally

DRUG

ibandronate sodium

Given orally

DRUG

zoledronic acid

Given IV

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

North Central Cancer Treatment Group

NETWORK

collaborator

Eastern Cooperative Oncology Group

NETWORK

collaborator

NSABP Foundation Inc

NETWORK

collaborator

Cancer and Leukemia Group B

NETWORK

collaborator

NCIC Clinical Trials Group

NETWORK

lead

SWOG Cancer Research Network

NETWORK